
Zürcher Kantonal Bank
Description
Zürcher Kantonalbank (ZKB) is a prominent cantonal bank based in Zurich, Switzerland, wholly owned by the canton. While it plays a crucial role in the Swiss financial landscape and actively supports the local economy, its operational model does not align with that of a traditional venture capital firm making direct equity investments in startups. ZKB's engagement with the startup ecosystem is primarily through providing banking services, debt financing, and strategic partnerships, rather than taking equity stakes.
The bank offers various financing solutions tailored for small and medium-sized enterprises (SMEs) and startups. For instance, through its "ZKB Start-up Finance" program, it provides loans and guarantees to young companies, helping them secure necessary capital for growth. These financing instruments are typically debt-based, with loan amounts potentially reaching up to CHF 1 million, which translates to approximately USD 1.1 million based on recent exchange rates. This support is designed to facilitate business development and innovation within the region.
Beyond direct financing, ZKB is also a significant patron of innovation through initiatives like the "ZKB Pionierpreis Technopark." This annual award recognizes and supports promising Swiss startups with prize money, fostering entrepreneurial spirit and technological advancement. The main prize for this competition is CHF 100,000, equivalent to roughly USD 110,000, serving as a grant rather than an equity investment.
In summary, Zürcher Kantonalbank functions as a corporate and retail bank that provides comprehensive financial services, including debt financing, to startups and established businesses. Its involvement in the startup ecosystem is robust, but it does not operate as an equity venture capital investor. Therefore, the concept of typical "first cheque sizes" in the context of equity investments is not applicable to ZKB's investment strategy.
Investor Profile
Zürcher Kantonal Bank has backed more than 176 startups, with 13 new investments in the last 12 months alone. The firm has led 22 rounds, about 13% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in Switzerland, Singapore, United Kingdom.
- Strong thematic focus on Health Care, Biotechnology, Medical Device.
- Led 1 rounds in the past year.
Stage Focus
- Seed (35%)
- Series A (32%)
- Series B (12%)
- Series Unknown (12%)
- Series C (2%)
- Debt Financing (2%)
- Convertible Note (2%)
- Pre Seed (2%)
- Angel (1%)
- Undisclosed (1%)
Country Focus
- Switzerland (95%)
- Singapore (1%)
- United Kingdom (1%)
- Germany (1%)
- Spain (1%)
- Japan (1%)
Industry Focus
- Health Care
- Biotechnology
- Medical Device
- Software
- Medical
- Information Technology
- Manufacturing
- Robotics
- Saas
- Pharmaceutical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.